Toremifene

From Wikipedia, the free encyclopedia

Toremifene
Systematic (IUPAC) name
2-[4-(4-chloro-1, 2-diphenyl-but-1-enyl)phenoxy]- N,N-dimethyl-ethanamine
Identifiers
CAS number 89778-26-7
ATC code L02BA02
PubChem 3005573
DrugBank APRD00391
Chemical data
Formula C26H28ClNO 
Mol. mass 405.959 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding more than 99.5%
Metabolism  ?
Half life 5 days
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.

[edit] Reference

  • Price N, Sartor O, Hutson T, Mariani S. Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer. Clin Prostate Cancer 2005;3:211-4. PMID 15882476.